PDF version of current issue

| Volume 4 Number 4,
Winter 2012

| Volume 4 Number 3,
Autumn 2011

| Volume 4 Number 2,
Summer 2011

Click to read PDF

| Volume 4 Number 1,
Spring 2011

Click to read PDF

Archives

| Volume 3, Number 4,
Winter 2011

Click to read PDF

| Volume 3, Number 3,
Autumn 2010

Click to read PDF

| Volume 3, Number 2,
Summer 2010

Click to read PDF

| Volume 3, Number 1,
Spring 2010

Click to read PDF

| Volume 2, Number 4,
Winter 2010
Press Run 127,000 copies printed Click to read PDF

| Volume 2 Number 3,
Autumn 2009 • 122,000 copies
Three Voter Initiatives Filed fopr California 2010 Ballot

Read as PDF Read as HTML

| Volume 2 No. 2,
Summer 2009 • 115,000 copies
US Supreme Court: State Cannabis Laws Stand

Read as HTML • Read as PDF

| Volume 2 No. 1
Spring 2009 • 85,000 copies
Ending Medi-Marijuana Raids "Now American Policy"
Read as HTML • Read as PDF

| Volume 1 No. 4,
Winter 2009 • 72,500 copies
Election Brings New Hope for Reform in 2009
Read as HTMLRead as PDF

| Volume 1 No. 3,
Autumn 2008 • 65,000copies
Flurry of Court Rulings Boost Medical Rights

Read as HTMLRead as PDF

| Volume 1 No. 2
Summer 2008 • 50,000 copies
California High Court Stands by State Law to Return Medical Marijuana

Read as HTMLRead as PDF (4.7MB)

| Volume 1 Number 1
Spring 2008 • 35,000 copies
San Francisco Adopts Medical Marijuana Sanctuary Ordinance

Read as HTMLRead as PDF (2.9MB)

Next issue: Spring 2012 • Deadline Feb. 10, 2012: Call us at 510-275-9311

California Medical Association calls for legalization of cannabis

November 30th, 2011

By Drs. David Ostrow and David Berman

American Academy of Cannabinoid Medicine

The largest state medical society in the US, the California Medical Association (CMA), has called for the legalization of cannabis in order to allow physicians to prescribe it to patients, to expand research and advance scientific knowledge of its therapeutic applications and mechanisms of action. CMA can now request the American Medical Assn. (AMA) to reconsider its own policy recommendations on cannabis and debate whether the AMA should take a similar position.

“CMA may be the first organization of its kind to take this position, but we won’t be the last,” said Dr. James T. Hay, CMA president-elect, in an Oct. 16, 2011 news release. “This was a carefully considered, deliberative decision made exclusively on medical and scientific grounds. As physicians, we need to have a better understanding about the benefits and risks of medicinal cannabis so that we can provide the best care possible to our patients.”

While the CMA’s new position does not recognize the extensive body of scientific research on the proven therapeutic uses of cannabis for multiple conditions, including neuropathic pain, muscle spasticity, glaucoma and chronic pain and wasting associated with terminal conditions such as advanced cancer, it is consistent with the American Academy of Cannabinoid Medicine (AACM) and the Academy of Clinical Medicine’s positions that adequate access to cannabis is necessary for a better understanding of its therapeutic mechanisms and the discovery of further medicinal uses.

Noting that CMA’s endorsement of the legalization of cannabis goes much further than its previous position supporting the development of a science-based approach to cannabinoid medicine, the AACM Board applauded the “courageous leadership of the CMA in challenging one of the central tenants of widely discredited propaganda [used to rationalize] a failed War on Drugs that has cost over one trillion dollars and countless lives.” As over 1,000 drug policy reform advocates were meeting in LA, federal agents were raiding legally licensed medicinal cannabis growers and suppliers and confiscating medical cannabis, often without cooperation or oversight by state and local authorities, some of whom condemned the raids.

“The CMA’s leadership on this critical issue should encourage all physicians and other qualified caregivers to lobby their professional associations to take a similar stand against cannabis prohibition,” the AACM statement continued, “in order that clinical use and research can be unleashed from unsubstantiated fears and Draconian measures [despite] the growing scientific and popular opinion that cannabis and many of its hundreds of active ingredients are both safer and less addictive than FDA-approved medications.“

If the AMA adopts the CMA position, it will restore the principles laid out by the AMA leadership in 1937 that the federal prohibition against the prescription of cannabis by physicians was a direct assault on the medical profession’s development of improved pharmacological therapy.

< |||| >